INGEN (IGNT) could quite possibly be a real money maker in 2010
So, I began to realize, I had absolutely no idea about what it was they were making and what it was for. But, I did have an analysis expert right in my own home, my wife. My wife is a RN at a local nursing home, where she specializes in alzheimer and dementia patients. I, after several tries, got her to read into the company and their medical products. She was absolutely blown away! She says "If we had some of these products, it would absolutely make my job a hell of a lot easier!" I, of coarse asked why. She goes on about The Oxyview Nasal Cannula in particular. And explains that this one product could save her employer thousands of dollars a year, and guard from potential lawsuits. She has since brought this product to the attention of her upper management, and they are in the process of purchasing a mass quantity of them. She is in line to receive a nice bonus for her idea, I mean, MY IDEA!
So, because of all of this, I decided to get in on Ingen (IGNT). Since I got in on this stock, nothing but great new has been poring out on this company.
On Jan 28, 2010, Ingen officially signed a contract with the Texas-based KGMA Business Solutions for pursuing U.S. Government contracts. KGMA had prepared and submitted the GSA application for Ingen on September 22, 2009. The application has been under review with the VA National Acquisition Center. KGMA has recently displayed a highly strong confidence level that the application is near completion and will be approved. "With more than 300 VA Hospitals in the USA, and even a larger market with the Department of Defense and several other government agencies, the Oxyview product line will be cataloged with GSA and KGMA will target and close various distribution channels," stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.
The company recently had a successful completion of Stage-I of the ISO audit that brings them just a month away from being ISO 13485 certified. With this $200,000 investment, the ISO certification closes strategic contracts and back orders of the company's Oxyview product line in China, Japan, Canada, Australia and the European Communities with projected sales of the Oxyview Smart Nasal Cannula for $10M in revenues, and the new I-Pulse Oximeter for an additional $1M in revenues in 2010.
On Feb 4th 2010, Scott R. Sand, Chief Executive Officer and Chairman of the Board released a statement about the emminent growth of the company. I'm not going to write it all out, but if you are interested you can read it all here: [http://www.otcmarkets.com/pink/quote...gnt&tabValue=1]
So, as you can see, my wife and I are really excited about this company and its potential. We are all looking for the next "Big Fish". I truly believe that Ingen is on track to being one in 2010 and beyond.